• Rewiring the Tumor Microenvironment: Strategic Applicatio...

  2025-10-20

  This thought-leadership article offers translational researchers a comprehensive, mechanistic, and strategic perspective on leveraging SB 202190—a highly selective p38 MAP kinase inhibitor—to dissect and therapeutically target the MAPK pathway in cancer, inflammation, and neurodegeneration. Integrating the latest assembloid model findings and industry trends, we chart a roadmap for deploying SB 202190 in advanced preclinical workflows that reflect real-world tumor complexity, drive actionable insights, and accelerate the journey from bench to bedside.

• Forskolin as a Precision Adenylate Cyclase Activator: Exp...

  2025-10-19

  Explore the multifaceted role of Forskolin as a direct adenylate cyclase activator in advanced cAMP signaling studies. This in-depth article reveals unique applications in human sensory neuron models and latent viral infection research, setting a new benchmark in biotechnology insights.

2 records 1/1 page